JP2018516244A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018516244A5 JP2018516244A5 JP2017554475A JP2017554475A JP2018516244A5 JP 2018516244 A5 JP2018516244 A5 JP 2018516244A5 JP 2017554475 A JP2017554475 A JP 2017554475A JP 2017554475 A JP2017554475 A JP 2017554475A JP 2018516244 A5 JP2018516244 A5 JP 2018516244A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- fra
- composition
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562149184P | 2015-04-17 | 2015-04-17 | |
| US62/149,184 | 2015-04-17 | ||
| PCT/US2016/027497 WO2016168440A1 (en) | 2015-04-17 | 2016-04-14 | Methods for treating lung cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018516244A JP2018516244A (ja) | 2018-06-21 |
| JP2018516244A5 true JP2018516244A5 (enExample) | 2019-03-28 |
Family
ID=55809240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017554475A Pending JP2018516244A (ja) | 2015-04-17 | 2016-04-14 | 肺がんを処置するための方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20180125970A1 (enExample) |
| EP (1) | EP3283886B1 (enExample) |
| JP (1) | JP2018516244A (enExample) |
| KR (1) | KR20170137848A (enExample) |
| CN (1) | CN107624071A (enExample) |
| AU (1) | AU2016248222A1 (enExample) |
| BR (1) | BR112017022320A2 (enExample) |
| CA (1) | CA2983126A1 (enExample) |
| IL (1) | IL255079A0 (enExample) |
| MX (1) | MX2017013390A (enExample) |
| RU (1) | RU2718780C9 (enExample) |
| SG (1) | SG11201708546UA (enExample) |
| WO (1) | WO2016168440A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006116592A2 (en) * | 2005-04-22 | 2006-11-02 | Morphotek, Inc. | Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cells |
| US20170247449A1 (en) * | 2014-06-06 | 2017-08-31 | Kyowa Hakko Kirin Co., Ltd | Therapeutic method and medicament for cancer patients by folr1-targeting drug and an antagonist for folic acid metabolism |
| US10822410B2 (en) | 2016-11-23 | 2020-11-03 | Eisai R&D Management Co., Ltd. | Anti-folate receptor alpha antibodies and uses thereof |
| US11873335B2 (en) | 2018-03-13 | 2024-01-16 | Phanes Therapeutics, Inc. | Anti-folate receptor 1 antibodies and uses thereof |
| CA3103369A1 (en) * | 2018-06-18 | 2019-12-26 | Medimmune Limited | Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer |
| CN110221052B (zh) * | 2019-06-17 | 2022-09-23 | 昆山德诺瑞尔生物科技有限公司 | Ppfibp1蛋白在制备肝癌术后预后评估试剂盒中的应用 |
| AU2023229967A1 (en) * | 2022-03-11 | 2024-08-08 | Astrazeneca Ab | A SCORING METHOD FOR AN ANTI-FRα ANTIBODY-DRUG CONJUGATE THERAPY |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1716179A2 (en) * | 2004-02-12 | 2006-11-02 | Morphotek, Inc. | Monoclonal antibodies that specifically bind to folate receptor alpha |
| WO2006116592A2 (en) * | 2005-04-22 | 2006-11-02 | Morphotek, Inc. | Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cells |
| GB0718167D0 (en) * | 2007-09-18 | 2007-10-31 | Cancer Rec Tech Ltd | Cancer marker and therapeutic target |
| CA2816991C (en) | 2010-11-05 | 2020-06-09 | Morphotek Inc. | Folate receptor alpha as a diagnostic and prognostic marker for folate receptor alpha-expressing cancers |
| EP3330291B1 (en) | 2011-07-15 | 2020-09-02 | Eisai R&D Management Co., Ltd. | Anti-folate receptor alpha antibodies and uses thereof |
-
2016
- 2016-04-14 MX MX2017013390A patent/MX2017013390A/es unknown
- 2016-04-14 CA CA2983126A patent/CA2983126A1/en not_active Abandoned
- 2016-04-14 CN CN201680028727.8A patent/CN107624071A/zh active Pending
- 2016-04-14 AU AU2016248222A patent/AU2016248222A1/en not_active Abandoned
- 2016-04-14 EP EP16718820.0A patent/EP3283886B1/en active Active
- 2016-04-14 JP JP2017554475A patent/JP2018516244A/ja active Pending
- 2016-04-14 KR KR1020177032864A patent/KR20170137848A/ko not_active Withdrawn
- 2016-04-14 SG SG11201708546UA patent/SG11201708546UA/en unknown
- 2016-04-14 WO PCT/US2016/027497 patent/WO2016168440A1/en not_active Ceased
- 2016-04-14 BR BR112017022320A patent/BR112017022320A2/pt not_active Application Discontinuation
- 2016-04-14 US US15/566,888 patent/US20180125970A1/en not_active Abandoned
- 2016-04-14 RU RU2017136863A patent/RU2718780C9/ru not_active IP Right Cessation
-
2017
- 2017-10-17 IL IL255079A patent/IL255079A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018516244A5 (enExample) | ||
| JP7325463B2 (ja) | がんの予後診断及び治療のための方法及び組成物 | |
| US20250154257A1 (en) | Treatment of lung cancer using a combination of an anti-pd-1 antibody and an anti-ctla-4 antibody | |
| AU2014312079B2 (en) | Diagnostic methods and compositions for treatment of glioblastoma | |
| US20220315657A1 (en) | Anti-pd-1 antibody for use in a method of treating a tumor | |
| RU2017136863A (ru) | Способы лечения рака легкого | |
| JP2020524694A (ja) | がんの処置における使用のためのＩＬ−１β結合性抗体 | |
| JP2016539083A5 (enExample) | ||
| KR20130055647A (ko) | 항암요법에 반응할 가능성이 증가된 환자를 확인하는 방법 | |
| TWI819011B (zh) | 以pd-1 軸結合拮抗劑、鉑劑及拓撲異構酶ii 抑制劑治療肺癌之方法 | |
| EP3169801A1 (en) | Diagnostic methods and compositions for treatment of glioblastoma | |
| US20200369762A1 (en) | Use of il-1beta binding antibodies | |
| US20250061965A1 (en) | Diagnostic and therapeutic methods for cancer | |
| WO2014205342A4 (en) | Methods for treatment of ovarian cancer | |
| JP6312660B2 (ja) | Ｔｋ１タンパク質の発現が亢進した結腸直腸癌患者に対する治療効果予測方法 | |
| WO2025080769A1 (en) | Methods of treating cancer | |
| Wang et al. | P-252 Real-world data: Different administration strategies of fruquintinib for metastatic colorectal cancer | |
| JPWO2022043538A5 (enExample) | ||
| CN115916182A (zh) | 用于治疗三阴性乳腺癌的方法和组合物 | |
| HK1230250A1 (en) | Diagnostic methods and compositions for treatment of glioblastoma | |
| HK1244302A1 (en) | Methods and compositions for prognosis and treatment of cancers |